Disclosure as per Regulation 30 of SEBI (LODR) Regulations 2015 Appointment of Parul Agrawal as Additional (Non-Executive Independent Director) of the company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has appointed Ms. Parul Agrawal (DIN: 11268580) as an Additional Non-Executive & Independent Director on the Board, effective 13th February 2026. The decision was taken at a Board meeting held on the same day. Ms. Agrawal is a graduate, born on 21 July 1986, and has provided a self-declaration confirming she is not debarred by SEBI or any other authority from holding a directorship. Her brief profile has been submitted to BSE as required under Regulation 30 of the SEBI Listing Regulations.
This is a routine governance update — the addition of an independent director strengthens the Board's composition in line with SEBI's listing requirements. No material impact on shareholders or stock price is expected from this appointment alone.